Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

Taking an antiviral medication for a year may prevent vision damage associated with shingles that affects the eye, according ...

The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...

Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, ...

Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye, according to ...

(MENAFN- IANS) New York, Oct 20 (IANS) A team of researchers has found that taking an antiviral medication for a year may prevent vision damage associated with shingles that affects the eye.

(CAAR Delhi), the product Enviva E0 101G is a phytogenic blend designed to improve animal feed intake, gut health, and ...

Year-long use of a typical antiviral treatment for shingles was particularly impactful in reducing complications when the condition eventually affected the eye ...

Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye, according to ...

Taking an antiviral medication for a year may prevent vision damage associated with shingles that affects the eye, according to new research led by faculty from the Perelman School of Medicine at ...

New research presented at the American Academy of Ophthalmology’s Cornea Subspecialty Day is part of the part of the 8-year ...